ST

Sonu Tyagi

Active Director Director DIN 10094780
DIN 10094780 First appointment Mar 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Sonu Tyagi

Data last updated:

Sonu Tyagi is a Director at Magnitude Pharmaceuticals Private Limited (since 2023). The company operates in Healthcare. Magnitude Pharmaceuticals Private Limited reported revenue of ₹38.1 Lakh (FY 2025).

DIN 10094780
Primary Designation Director
Industry Healthcare
First Appointment 28 Mar 2023
Oldest Company Age 4 yrs
Largest company Magnitude Pharmaceuticals Private Limited · ₹38.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Mar 20232022₹38.1 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Magnitude Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sonu Tyagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonu Tyagi

Sonu Tyagi currently holds 1 directorship: Magnitude Pharmaceuticals Private Limited (Director, since 28 Mar 2023, revenue ₹38.1 Lakh (FY 2025)).

Sonu Tyagi was first appointed on 28 Mar 2023 as Director at Magnitude Pharmaceuticals Private Limited.

The current boards of Sonu Tyagi's companies include Prateek Sharma (Magnitude Pharmaceuticals Private Limited), Ram Lal Sharma (Magnitude Pharmaceuticals Private Limited), Shanu Sharma (Magnitude Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available